RiceBran Technologies Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	no data
Participación del CEO	n/a
Permanencia media de la dirección	5.3yrs
Promedio de permanencia en la Junta Directiva	6.5yrs

Actualizaciones recientes de la dirección

Recent updates

CEO

RiceBran Technologies no tiene CEO, o no tenemos datos al respecto.

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Eric Tompkins	Executive Chairman	less than a year	sin datos	0.43% $ 5.0k
William Keneally	Interim CFO & Secretary	less than a year	sin datos	0% $ 0
Rani Patel	Chief Science Officer	18yrs	sin datos	sin datos
Sherry Rhoads	Vice President of Compliance	5.3yrs	sin datos	sin datos
Joseph Gutman	Strategic Consultant & Member of Medical Advisory Board	17.3yrs	sin datos	sin datos

5.3yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de NTQ es experimentado (5.3 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Eric Tompkins	Executive Chairman	less than a year	sin datos	0.43% $ 5.0k
Joseph Gutman	Strategic Consultant & Member of Medical Advisory Board	17.3yrs	sin datos	sin datos
David Chemerow	Independent Director	5.3yrs	US$122.50k	2.32% $ 26.5k
Barbara Levine	Member of the Scientific Advisory Board	19.2yrs	sin datos	sin datos
Eliot Drell	Chairman of Medical Advisory Board	no data	US$4.26k	sin datos
Harold Stein	Member of Medical Advisory Board	18.8yrs	sin datos	sin datos
Brent Rosenthal	Lead Independent Director	7.6yrs	US$144.25k	2.86% $ 32.8k
James Flynn	Independent Director	less than a year	sin datos	sin datos
Georgina Russell	Independent Director	less than a year	sin datos	sin datos

6.5yrs

Permanencia media

66yo

Promedio de edad

Junta con experiencia: La junta directiva de NTQ se considera experimentada (6.5 años de antigüedad promedio).

RiceBran Technologies Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

RiceBran Technologies Announces Board Appointments

RiceBran Technologies, Annual General Meeting, Oct 16, 2023

RiceBran Technologies, Annual General Meeting, Oct 10, 2023

Ricebran Technologies Announces Board Changes

RiceBran Technologies, Annual General Meeting, Jul 14, 2022

Less than half of directors are independent

Recent updates

RiceBran Technologies Announces Board Appointments

RiceBran Technologies announced delayed 10-Q filing

RiceBran Technologies(OTCPK:RIBT) dropped from S&P TMI Index

Ricebran Technologies Receives Staff Delisting Determination from Nasdaq Due to Non-Compliance with the Minimum $2,500,000 Stockholders’ Equity Requirement for Continued Listing as Set Forth in Nasdaq Listing Rule 5550(b)

Ricebran Technologies Receives Non-Compliance Notice from Nasdaq

RiceBran Technologies, Annual General Meeting, Oct 16, 2023

RiceBran Technologies announced delayed 10-Q filing

RiceBran Technologies, Annual General Meeting, Oct 10, 2023

Stabil Nutrition, LLC acquired Stabilized Rice Bran Business from RiceBran Technologies (NasdaqCM:RIBT) for $1.8 million.

RiceBran Technologies Receives Notice from the Staff of the Nasdaq Regarding Non-Compliance with Nasdaq Minimum Bid Price Requirement

Ricebran Technologies Announces Board Changes

First quarter 2023 earnings released: US$0.31 loss per share (vs US$0.29 loss in 1Q 2022)

Full year 2022 earnings released: US$1.43 loss per share (vs US$1.88 loss in FY 2021)

Third quarter 2022 earnings released: US$0.38 loss per share (vs US$0.47 loss in 3Q 2021)

RiceBran Technologies has completed a Follow-on Equity Offering in the amount of $1.499968 million.

RiceBran Technologies has completed a Follow-on Equity Offering in the amount of $1.5 million.

RiceBran Technologies Regains Compliance with Nasdaq Bid Price Rule

RiceBran Technologies, Annual General Meeting, Jul 14, 2022

Less than half of directors are independent

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Third quarter 2021 earnings released: US$0.047 loss per share (vs US$0.068 loss in 3Q 2020)

Second quarter 2021 earnings released: US$0.042 loss per share (vs US$0.099 loss in 2Q 2020)

First quarter 2021 earnings released: EPS US$0.013 (vs US$0.076 loss in 1Q 2020)

CEO

Equipo directivo

Permanencia media

Miembros de la Junta

Permanencia media

Promedio de edad